Does coronary-artery bypass grafting improve survival in patients with multivessel coronary disease?
CABG improves survival in patients with multivessel coronary disease, with the greatest benefit seen in high-risk subgroups such as those with diabetes or left ventricular dysfunction.
Coronary-artery bypass grafting (CABG) is very commonly performed. CABG improves survival among patients with multivessel coronary disease; those with more severe coronary disease, diabetes, or left ventricular dysfunction are especially likely to benefit.
Alexander et al. (Wed,) studied this question.